Polar Capital’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,900,000
Closed -$7.03M 287
2017
Q4
$7.03M Buy
1,900,000
+650,000
+52% +$2.41M 0.07% 182
2017
Q3
$5.11M Buy
1,250,000
+250,000
+25% +$1.02M 0.06% 194
2017
Q2
$3.72M Buy
1,000,000
+450,000
+82% +$1.67M 0.05% 201
2017
Q1
$2.28M Buy
+550,000
New +$2.28M 0.03% 224